Drug design strategies for ocular therapeutics
- 1 June 1994
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 14 (2-3) , 269-279
- https://doi.org/10.1016/0169-409x(94)90044-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Systemic Effects of Medications Used To Treat GlaucomaAnnals of Internal Medicine, 1990
- Review: Development of D-Timolol for the Treatment of Glaucoma and Ocular HypertensionJournal of Ocular Pharmacology and Therapeutics, 1990
- BETA-ADRENERGIC THERAPY FOR GLAUCOMAInternational Ophthalmology Clinics, 1990
- SYSTEMIC ADVERSE REACTIONS TO GLAUCOMA MEDICATIONSInternational Ophthalmology Clinics, 1989
- Formation of adrenaline in the iris-ciliary body from adrenalone diestersExperimental Eye Research, 1984
- Improved Delivery Through Biological Membranes. XVII. A Site-Specific Chemical Delivery System as a Short-Acting Mydriatic AgentPharmaceutical Research, 1984
- Problems of delivery of drugs to the brainPharmacology & Therapeutics, 1982
- Enzymes of mercapturate synthesis and other drug-metabolizing reactions-specific localization in the eyeExperimental Eye Research, 1981
- Mammalian Carbonyl ReductasesDrug Metabolism Reviews, 1980
- Treatment of Ocular Hypertension by Adrenalin and Diverse Sympathomimetic Amines*American Journal of Ophthalmology, 1955